Related Experiment Videos

Effect of chronic lung disease on blood pressure levels at follow up

A Greenough1, E F Emery

  • 1Department of Child Health, King's College Hospital, London, United Kingdom.

Insights

Neonatal chronic lung disease (CLD) did not lead to significant blood pressure (BP) elevation in preterm infants. Follow-up monitoring showed no hypertension symptoms or notable BP differences compared to controls.

Area of Science:

  • Neonatology
  • Pediatric Cardiology
  • Respiratory Medicine

Background:

  • Neonatal chronic lung disease (CLD) is a significant concern in preterm infants.
  • Potential long-term cardiovascular complications, including hypertension, require investigation.

Purpose of the Study:

  • To assess the incidence of elevated blood pressure (BP) in preterm infants with CLD.
  • To compare BP levels in infants with CLD to matched controls over a 6-month period.

Main Methods:

  • Prospective follow-up of 13 preterm infants with CLD and 13 matched controls.
  • Monthly clinical examinations and noninvasive Doppler blood pressure (BP) measurements for 6 months.

Main Results:

  • No infant in either group developed symptoms of hypertension.
  • No statistically significant differences in BP levels were observed between the CLD group and the control group at follow-up.

Conclusions:

  • Significant blood pressure elevation appears uncommon in preterm infants following neonatal chronic lung disease.
  • Neonatal CLD may not be a primary risk factor for developing hypertension in early infancy.

Related Concept Videos